CIK 0001815974
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Anebulo Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ANEB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851170950
- Phone
- +1 737-203-5270
- Business address
- C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 400 shares at $6.59 ($2,634)
- 4 Open-market buy Director bought 412 shares at $5.90 ($2,429)
- 4 Open-market buy Director bought 4,500 shares at $5.93 ($26,685)
- 4 Open-market buy Director bought 13,836 shares at $5.30 ($73,331)
- 4/A Grant or award Director acquired 714,250 shares (grant or award)
- 4 Grant or award Director acquired 714,286 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 3 · 56 filings